Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.

about

Development of the S3Pvac vaccine against murine Taenia crassiceps cysticercosis: a historical review.A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.

P2860

Q38081501-74D264A9-6863-4243-B322-AAB29C132682 Q51336011-9C24A86C-7C49-4845-B48B-FB1A4D96CFE3

P2860

Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.

Item

http://www.wikidata.org/entity/Q42998966

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Prime-boost vaccinations using ...... vaccines: an ELISPOT analysis.

@en

Prime-boost vaccinations using ...... vaccines: an ELISPOT analysis.

@nl

type

Item

label

Prime-boost vaccinations using ...... vaccines: an ELISPOT analysis.

@en

Prime-boost vaccinations using ...... vaccines: an ELISPOT analysis.

@nl

prefLabel

Prime-boost vaccinations using ...... vaccines: an ELISPOT analysis.

@en

Prime-boost vaccinations using ...... vaccines: an ELISPOT analysis.

@nl

P1476

Prime-boost vaccinations using ...... vaccines: an ELISPOT analysis.

@en

P2093

Itaru Anraku

http://www.w3.org/2001/XMLSchema#string

Joy Gardner

http://www.w3.org/2001/XMLSchema#string

Paweena Rattanasena

http://www.w3.org/2001/XMLSchema#string

Thuy T Le

http://www.w3.org/2001/XMLSchema#string

Xiang Ju Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.

A Heterologous DNA Prime-Venezuelan Equine Encephalitis Virus Replicon Particle Boost Dengue Vaccine Regimen Affords Complete Protection from Virus Challenge in Cynomolgus Macaques

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

Tetracycline-inducible packaging cell line for production of flavivirus replicon particles

Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.

Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice.

Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies.

DNA vaccines: ready for prime time?

P304

426-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ICB.2010.99

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexander A. Khromykh

Andreas Suhrbier

P577

2010-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20680025

http://www.w3.org/2001/XMLSchema#string

Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.

about

P2860

P2860

Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698